We have compiled a timeline to commemorate the 40th anniversary of the Journal of Antimicrobial Chemotherapy (JAC). The timeline highlights key milestones and articles in JAC’s history, including top cited, top downloaded and articles with high Altmetric scores. All articles featured in the timeline will be freely accessible until the 31st December 2016. Scroll right to start exploring.
The British Society for Antimicrobial Chemotherapy (BSAC) is formed with the intention of coordinating research into many new antimicrobial agents. Alasdair M. Geddes, Chairman of the first Editorial Board, looks back on the early years of BSAC and JAC.
J. D. Williams is JAC's first Editor-in-Chief.
The Journal of Antimicrobial Chemotherapy launches. The Journal sets out to cater to a broad church of disciplines involved in the development and use of antibiotics and related agents, attracting authors and readers from the BSAC and beyond. The Journal’s first editorial was written by the first Editor-in-Chief, J. D. Williams.
Ian Phillips of St Thomas’ Hospital, London takes over as the Journal’s Editor-in-Chief and introduces a new section in the first issue of each volume of the Journal, providing detailed guidance to authors.
Does administering antifungal drugs in conjunction with liposomes enhance therapeutic activity in rodents?
David Speller of the Bristol Royal Infirmary becomes JAC’s new Editor-in-Chief. He and his team “wish to increase the proportion of articles dealing with well-conducted clinical investigations, and to evoke a vigorous correspondence on antimicrobial matters”.
Roger Finch fulfils the role of JAC’s Editor-in-Chief.
“There are relatively few specific antifungal agents...for the treatment of systemic mycoses, yet the incidence of such infections, particularly of those caused by Candida species among immunocompromised patients, is generally considered to have become extremely high.”
Martin Wood becomes the new Editor-in-Chief of JAC.
JAC describes a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin (MIC 8 mg/L).
Which agents are more active than ciprofloxacin against gram-positive cocci?
JAC welcomes David Reeves as its new Editor-in-Chief.
Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infections.
Biosurfactants have great potential for use in the medical science arena waiting to be fully exploited.
Alan Johnson takes over as JAC’s Editor-in-Chief.
“There is an urgent need for research into the effectiveness of combinations of oral antibiotics in the treatment of complicated UTI in ambulatory care and the impact on the epidemiology of resistance.”
How can resistance to a STAT-C develop?
The Journal’s Impact Factor exceeds 5 for the first time.
Is antimicrobial stewardship associated with improved antimicrobial utilization in the intensive care unit?
Explore challenges in sepsis care and opportunities for further improvements.
Which antibiotics are most commonly prescribed during ambulatory visits in the US? Find out in a study of antibiotic prescribing for adults in ambulatory care in the USA, 2007–09.
“Antimicrobial stewardship, or rather the lack of it, is the most important challenge today.” JAC welcomes Peter Donnelly as its new Editor-in-Chief.
Do scientists have a responsibility to monitor and reduce our use of antibiotics?
Is antibacterial soap more effective than plain soap when hand-washing?
Celebrate JAC’s 40th year and learn about the history of the Journal in Peter Donnelly’s editorial: ‘Celebrating 40 years of the Journal’.
The BSAC Standing Committee on Antimicrobial Susceptibility Testing is one of several European national breakpoint committees that agreed in 2002 to harmonize clinical MIC breakpoints.
We'd love to hear from you. Please send questions or feedback to the below email addresses.
Before contacting us, you may wish to visit our FAQs page which has lots of useful info on Tiki-Toki.
We can be contacted by email at: hello@tiki-toki.com.
You can also follow us on twitter at twitter.com/tiki_toki.
If you are having any problems with Tiki-Toki, please contact us as at: help@tiki-toki.com
Close